Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

AC Immune begins first-in-human study of ACI-12589 as diagnostic for Parkinson's disease

Feb. 10, 2021

PaxMedica reports phase II data on PAX-101 for autism spectrum disorder

Feb. 10, 2021

European Commission approves additional indication for clopidogrel

Feb. 10, 2021

Kymera Therapeutics patents CRBN inhibitors

Feb. 8, 2021

Huaxiasheng Pharmaceutical patents AChE and NO production inhibitors

Feb. 5, 2021

Roche discloses new monoglyceride lipase inhibitors

Feb. 4, 2021

CRY1 protein activators allow circadian clock manipulation with light

Feb. 4, 2021

FDA authorizes initiation of pivotal phase III study of NE-3107 in AD

Feb. 4, 2021

University of Southern California and collaborators patent opioid receptor agonists

Feb. 3, 2021

Cassava Sciences presents interim analysis data for simufilam in patients with Alzheimer's disease

Feb. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...